annual CFF:
$348.00K-$3.19M(-90.18%)Summary
- As of today (September 18, 2025), AMLX annual cash flow from financing activities is $348.00 thousand, with the most recent change of -$3.19 million (-90.18%) on December 31, 2024.
- During the last 3 years, AMLX annual CFF has fallen by -$158.16 million (-99.78%).
- AMLX annual CFF is now -99.92% below its all-time high of $431.79 million, reached on December 31, 2022.
Performance
AMLX Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
-$31.00K-$65.69M(-100.05%)Summary
- As of today (September 18, 2025), AMLX quarterly cash flow from financing activities is -$31.00 thousand, with the most recent change of -$65.69 million (-100.05%) on June 1, 2025.
- Over the past year, AMLX quarterly CFF has dropped by -$58.00 thousand (-214.81%).
- AMLX quarterly CFF is now -100.01% below its all-time high of $232.16 million, reached on December 31, 2022.
Performance
AMLX quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$65.82M-$58.00K(-0.09%)Summary
- As of today (September 18, 2025), AMLX TTM cash flow from financing activities is $65.82 million, with the most recent change of -$58.00 thousand (-0.09%) on June 1, 2025.
- Over the past year, AMLX TTM CFF has increased by +$64.54 million (+5054.35%).
- AMLX TTM CFF is now -84.76% below its all-time high of $431.79 million, reached on December 31, 2022.
Performance
AMLX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
AMLX Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -90.2% | -214.8% | +5054.4% |
| 3 y3 years | -99.8% | +96.3% | -67.0% |
| 5 y5 years | -47.9% | - | - |
AMLX Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -99.9% | at low | -100.0% | +96.3% | -84.8% | >+9999.0% |
| 5 y | 5-year | -99.9% | at low | -100.0% | +96.3% | -84.8% | >+9999.0% |
| alltime | all time | -99.9% | at low | -100.0% | +96.3% | -84.8% | >+9999.0% |
AMLX Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$31.00K(-100.0%) | $65.82M(-0.1%) |
| Mar 2025 | - | $65.66M(>+9900.0%) | $65.88M(>+9900.0%) |
| Dec 2024 | $348.00K(-90.2%) | $110.00K(+37.5%) | $348.00K(-25.6%) |
| Sep 2024 | - | $80.00K(+196.3%) | $468.00K(-63.4%) |
| Jun 2024 | - | $27.00K(-79.4%) | $1.28M(-51.5%) |
| Mar 2024 | - | $131.00K(-43.0%) | $2.63M(-25.7%) |
| Dec 2023 | $3.54M | $230.00K(-74.1%) | $3.54M(-98.5%) |
| Sep 2023 | - | $889.00K(-35.8%) | $235.47M(+0.4%) |
| Jun 2023 | - | $1.38M(+33.1%) | $234.59M(+1.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | $1.04M(-99.6%) | $232.37M(-46.2%) |
| Dec 2022 | $431.79M(+172.4%) | $232.16M(>+9900.0%) | $431.79M(+116.3%) |
| Sep 2022 | - | $0.00(-100.0%) | $199.63M(0.0%) |
| Jun 2022 | - | -$828.00K(-100.4%) | $199.63M(-1.4%) |
| Mar 2022 | - | $200.46M(>+9900.0%) | $202.45M(+625.1%) |
| Dec 2021 | $158.51M(+238.5%) | - | - |
| Jun 2021 | - | $1.99M(-92.3%) | $27.92M(+7.7%) |
| Mar 2021 | - | $25.93M | $25.93M |
| Dec 2020 | $46.82M(+6909.4%) | - | - |
| Dec 2019 | $668.00K | - | - |
FAQ
- What is Amylyx Pharmaceuticals, Inc. annual cash flow from financing activities?
- What is the all time high annual CFF for Amylyx Pharmaceuticals, Inc.?
- What is Amylyx Pharmaceuticals, Inc. annual CFF year-on-year change?
- What is Amylyx Pharmaceuticals, Inc. quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Amylyx Pharmaceuticals, Inc.?
- What is Amylyx Pharmaceuticals, Inc. quarterly CFF year-on-year change?
- What is Amylyx Pharmaceuticals, Inc. TTM cash flow from financing activities?
- What is the all time high TTM CFF for Amylyx Pharmaceuticals, Inc.?
- What is Amylyx Pharmaceuticals, Inc. TTM CFF year-on-year change?
What is Amylyx Pharmaceuticals, Inc. annual cash flow from financing activities?
The current annual CFF of AMLX is $348.00K
What is the all time high annual CFF for Amylyx Pharmaceuticals, Inc.?
Amylyx Pharmaceuticals, Inc. all-time high annual cash flow from financing activities is $431.79M
What is Amylyx Pharmaceuticals, Inc. annual CFF year-on-year change?
Over the past year, AMLX annual cash flow from financing activities has changed by -$3.19M (-90.18%)
What is Amylyx Pharmaceuticals, Inc. quarterly cash flow from financing activities?
The current quarterly CFF of AMLX is -$31.00K
What is the all time high quarterly CFF for Amylyx Pharmaceuticals, Inc.?
Amylyx Pharmaceuticals, Inc. all-time high quarterly cash flow from financing activities is $232.16M
What is Amylyx Pharmaceuticals, Inc. quarterly CFF year-on-year change?
Over the past year, AMLX quarterly cash flow from financing activities has changed by -$58.00K (-214.81%)
What is Amylyx Pharmaceuticals, Inc. TTM cash flow from financing activities?
The current TTM CFF of AMLX is $65.82M
What is the all time high TTM CFF for Amylyx Pharmaceuticals, Inc.?
Amylyx Pharmaceuticals, Inc. all-time high TTM cash flow from financing activities is $431.79M
What is Amylyx Pharmaceuticals, Inc. TTM CFF year-on-year change?
Over the past year, AMLX TTM cash flow from financing activities has changed by +$64.54M (+5054.35%)